Come up with a name for your new list and we'll add to it:
SensiGen raised a round of funding on , . Investors include
Delaware Crossing Investment Group.
SensiGen is a biotechnology company. They specialize creating tests to screen for diseases more efficiently and quickly. Their goal is to lower the overall costs of diagnosing serious diseases, usuall…